USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stemcell Technologies Canada Inc.

USPTO PatentsView assignee record - 13 granted patents across 11 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

13
Total patents granted
11
CPC technology areas
18.1
Avg claims per patent
-
5-year filing velocity

The verdict

Stemcell holds 13 US patents across 11 technology areas, rank #21,767 of 50,000 tracked assignees.

#21,767
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.7/100)
18.1
avg claims per patent

Portfolio overview

Stemcell Technologies Canada Inc. has been granted 13 US utility patents between 2023 and 2025, placing Stemcell Technologies Canada Inc. at rank #21,767 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Stemcell Technologies Canada Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 13 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Stemcell Technologies Canada Inc.'s 18.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Stemcell Technologies Canada Inc. against peers pursuing similar technology classes.

How does Stemcell compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Stemcell holds 13 patents, placing it at rank #21,767 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Stemcell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

0246810 202320242025 8
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Stemcell Technologies Canada Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 2 15.4%
2024 3 23.1%
2025 8 61.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#21,767

Across all tracked assignees

Innovation Score

51.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Stemcell Technologies Canada Inc. hold?
Stemcell Technologies Canada Inc. holds 13 US granted patents filed between 2023 and 2025, spanning 11 technology areas.
What is Stemcell Technologies Canada Inc.'s Innovation Score?
Stemcell Technologies Canada Inc. has an Innovation Score of 51.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Stemcell Technologies Canada Inc. focus on?
Stemcell Technologies Canada Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 8 patents. The company has filed patents in 11 CPC subclasses total.
Is Stemcell Technologies Canada Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Stemcell Technologies Canada Inc..
What does claim depth mean for Stemcell Technologies Canada Inc.'s patents?
Stemcell Technologies Canada Inc.'s patents average 18.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Stemcell Technologies Canada Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Stemcell's 13 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Stemcell ranks #21,767 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.